Incyte Announces Additional FDA Approval of Opzelura® (Ruxolitinib) Cream in Children Ages 2-11 with Atopic Dermatitis ...

The U.S. Food and Drug Administration has approved Incyte's eczema treatment for children aged between 2 and 11 years, the ...

Adults with atopic dermatitis, whether diagnosed during childhood or adulthood, experienced higher rates of suicidal thoughts ...

Nektar Therapeutics (Nasdaq: NKTR) today announced new data from the ongoing REZOLVE-AD Phase 2b study of rezpegaldesleukin, ...

New analysis of ZORYVE foam 0.3% demonstrates reduction in signs and symptoms of seborrheic dermatitis in individuals with diverse skin typesNew ...

First FDA-approved medication for atopic dermatitis (eczema), plaque psoriasis, and seborrheic dermatitis to win prominent “Breakthrough ...

World Atopic Eczema Day 2025 calls for early intervention, better care, and greater awareness of the hidden toll of atopic ...

Anyone can have eczema, though CDC data shows that it’s disproportionately diagnosed in women. This complex condition is strongly linked to allergies, asthma, and other autoimmune issues. Common ...

Constant loss of smell, facial pain and a blocked nose are a reality for the 10 per cent of people living with chronic ...

More than half of Americans aged 40 and over have high blood pressure. There are typically no symptoms, but left untreated, it can be deadly. NPR's Allison Aubrey reports on new recommendations aimed ...

As children return to school, common skin conditions that were previously under control may flare up once again, thanks to a ...